New Survey Reveals Major Gap Between Vaccine Support and Uptake, Impacting Texas Businesses

A recent survey conducted by the National Foundation for Infectious Diseases (NFID) has uncovered a significant disconnect between Americans' support for vaccines and their actual vaccination behavior. According to the survey, 77% of adults express positive views about vaccines, yet only 48% have received at least one of the four key respiratory vaccines—flu, RSV, pneumococcal disease, or Covid-19—in the past year. This gap, described as widespread uncertainty, presents a critical opportunity for healthcare professionals, policymakers, and businesses to enhance public health and economic resilience in Texas.

The survey results highlight that many adults are unclear about which vaccines they need and how often to get them. This knowledge gap is particularly concerning given the proven benefits of vaccination, including reduced illness severity, fewer hospitalizations, and lower healthcare costs. In Texas, where a large and diverse population relies on a robust healthcare system, improving vaccine uptake could significantly alleviate the economic burden of infectious diseases on employers and the state's economy.

Speaking during the release of the survey findings, Dr. Robert Hopkins, Jr., Medical Director of NFID, emphasized the lost opportunity to protect families and communities when vaccination rates lag. The survey also found that about 60% of respondents trust healthcare professionals for health information, indicating that medical providers are well-positioned to offer clear, consistent vaccine recommendations. This trust is a valuable asset that Texas healthcare providers can leverage to close the gap between positive attitudes and action.

Accessibility remains another hurdle: 22% of participants reported challenges in obtaining respiratory vaccines, such as vaccine shortages or long wait times. Addressing these barriers is essential to improving uptake, and every increase in vaccination translates into measurable public health and economic benefits. For Texas businesses, a healthier workforce means fewer sick days, lower healthcare costs, and greater productivity—key factors for sustaining the state's economic momentum.

Parallel efforts by companies like Co-Diagnostics Inc. (NASDAQ: CODX) are developing accessible and affordable testing kits for home and non-hospital settings. Such innovations can facilitate early diagnosis and prevent diseases from progressing to severe stages, complementing vaccination efforts. The work of BioMedWire, a specialized communications platform focused on biotechnology and life sciences, is part of the Dynamic Brand Portfolio at IBN, which delivers InvestorWire solutions and editorial syndication to 5,000+ outlets, helping to disseminate critical health information.

For Texas, the implications are clear: bridging the vaccine confidence-uptake gap can protect public health, reduce economic losses from preventable diseases, and support a thriving business environment. As the state continues to grow, coordinated efforts among healthcare providers, employers, and innovators will be key to realizing these benefits.